Patents Assigned to ASTRAZENECA UK LIMITED AB
  • Publication number: 20100160286
    Abstract: Compounds of formula (I) wherein R1, R2, R3, and HET-1 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.
    Type: Application
    Filed: August 7, 2006
    Publication date: June 24, 2010
    Applicant: ASTRAZENECA UK LIMITED AB
    Inventors: Darren McKerrecher, Gordon Kurt Pike, James Michael Warning